8th Jun 2006 09:38
AGI Therapeutics plc08 June 2006 8 June 2006 AGI Therapeutics plc ('AGI' or the 'Company') Award of Options Following his appointment as President of AGI Therapeutics Inc, (the Company'sUS subsidiary), AGI has awarded Dr. David Young options over 758,394 ordinaryshares of €0.01 each in the share capital of the Company in accordance with theCompany's share option scheme and with an exercise price of €1.35. This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai